Effects of TNF-α and curcumin on the expression of thrombomodulin and endothelial protein C receptor in human endothelial cells

Vilcek, 1991, Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions, J. Biol. Chem., 266, 7313, 10.1016/S0021-9258(20)89445-9 Bevilacqua, 1986, Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1, Proc. Natl. Acad. Sci. U. S. A., 83, 4533, 10.1073/pnas.83.12.4533 Nawroth, 1986, Modulation of endothelial cell hemostatic properties by tumor necrosis factor, J. Exp. Med., 163, 740, 10.1084/jem.163.3.740 Schleef, 1988, Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor, J. Biol. Chem., 263, 5797, 10.1016/S0021-9258(18)60636-2 Bevilacqua, 1989, Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins, Science, 243, 1160, 10.1126/science.2466335 Yoshii, 2003, Expression of thrombomodulin in human aortic smooth muscle cells with special reference to atherosclerotic lesion types and age differences, Med. Electron Microsc., 36, 165, 10.1007/s00795-003-0212-5 Wood, 2003, NMR structures reveal how oxidation inactivates thrombomodulin, Biochemistry, 42, 11932, 10.1021/bi034646q Dorffler-Melly, 2003, Functional thrombomodulin deficiency causes enhanced thrombus growth in a murine model of carotid artery thrombosis, Basic Res. Cardiol., 98, 347, 10.1007/s00395-003-0416-9 Myles, 2003, Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation, J. Biol. Chem., 278, 51059, 10.1074/jbc.M306977200 Esmon, 2003, The protein C pathway, Chest, 124, 26S, 10.1378/chest.124.3_suppl.26S Esmon, 2002, New mechanisms for vascular control of inflammation mediated by natural anticoagulant proteins, J. Exp. Med., 196, 561, 10.1084/jem.20021088 Fukudome, 1994, Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor, J. Biol. Chem., 269, 26486, 10.1016/S0021-9258(18)47220-1 Villoutreix, 1999, Structural prediction and analysis of endothelial cell protein C/activated protein C receptor, Protein Eng., 12, 833, 10.1093/protein/12.10.833 Laszik, 1997, Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway, Circulation, 96, 3633, 10.1161/01.CIR.96.10.3633 Ye, 1999, The endothelial cell protein C receptor (EPCR) functions as a primary receptor for protein C activation on endothelial cells in arteries, veins, and capillaries, Biochem. Biophys. Res. Commun., 259, 671, 10.1006/bbrc.1999.0846 Fukudome, 1998, Activation mechanism of anticoagulant protein C in large blood vessels involving the endothelial cell protein C receptor, J. Exp. Med., 187, 1029, 10.1084/jem.187.7.1029 Espana, 2002, Inherited abnormalities in the protein C activation pathway, Pathophysiol. Haemost. Thromb., 32, 241, 10.1159/000073573 Singh, 1996, Curcumin inhibits the proliferation and cell cycle progression of human umbilical vein endothelial cell, Cancer Lett., 107, 109, 10.1016/0304-3835(96)04357-1 Ishii, 2000, Verotoxin-1 induces tissue factor expression in human umbilical vein endothelial cells through activation of NF-kappaB/Rel and AP-1, Thromb. Haemost., 84, 712, 10.1055/s-0037-1614092 Pendurthi, 1997, Inhibition of tissue factor gene activation in cultured endothelial cells by curcumin. Suppression of activation of transcription factors Egr-1, AP-1, and NF-kappa B, Arterioscler. Thromb. Vasc. Biol., 17, 3406, 10.1161/01.ATV.17.12.3406 Bierhaus, 1997, The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-kappa B, Thromb. Haemost., 77, 772, 10.1055/s-0038-1656049 Yamagishi, 2004, Azelnidipine, a newly developed long-acting calcium antagonist, inhibits tumor necrosis factor-alpha-induced interleukin-8 expression in endothelial cells through its anti-oxidative properties, J. Cardiovasc. Pharmacol., 43, 724, 10.1097/00005344-200405000-00016 Kumar, 1998, Curcumin (Diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation, Biochem. Pharmacol., 55, 775, 10.1016/S0006-2952(97)00557-1 Huang, 2003, Thrombomodulin-mediated cell adhesion: involvement of its lectin-like domain, J. Biol. Chem., 278, 46750, 10.1074/jbc.M305216200 Conway, 1988, Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells, Mol. Cell. Biol., 8, 5588, 10.1128/MCB.8.12.5588 Kapiotis, 1991, Interleukin-4 counteracts pyrogen-induced downregulation of thrombomodulin in cultured human vascular endothelial cells, Blood, 78, 410, 10.1182/blood.V78.2.410.410 Ishii, 1992, Retinoic acid counteracts both the downregulation of thrombomodulin and the induction of tissue factor in cultured human endothelial cells exposed to tumor necrosis factor, Blood, 80, 2556, 10.1182/blood.V80.10.2556.2556 Murugesan, 2000, Endothelial cell expression of monocyte chemotactic protein-1, tissue factor, and thrombomodulin on hydrophilic plasma polymers, J. Biomed. Mater. Res., 49, 396, 10.1002/(SICI)1097-4636(20000305)49:3<396::AID-JBM13>3.0.CO;2-H Lentz, 1991, Regulation of thrombomodulin by tumor necrosis factor-alpha: comparison of transcriptional and posttranscriptional mechanisms, Blood, 77, 542, 10.1182/blood.V77.3.542.542 Scarpati, 1989, Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor, J. Biol. Chem., 264, 20705, 10.1016/S0021-9258(19)47120-2 Moore, 1989, Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture, Blood, 73, 159, 10.1182/blood.V73.1.159.159 Esmon, 2004, Crosstalk between inflammation and thrombosis, Maturitas, 47, 305, 10.1016/j.maturitas.2003.10.015 Arbiser, 1998, Curcumin is an in vivo inhibitor of angiogenesis, Mol. Med., 4, 376, 10.1007/BF03401744 Thaloor, 1998, Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin, Cell Growth Differ., 9, 305 Hanazawa, 1993, Tumor necrosis factor-alpha induces expression of monocyte chemoattractant JE via fos and jun genes in clonal osteoblastic MC3T3-E1 cells, J. Biol. Chem., 268, 9526, 10.1016/S0021-9258(18)98383-3 Kanda, 1998, Comparison of ICAM-1 and VCAM-1 expression in various human endothelial cell types and smooth muscle cells, Endothelium, 6, 33, 10.3109/10623329809053403 Ades, 1992, HMEC-1: establishment of an immortalized human microvascular endothelial cell line, J. Invest. Dermatol., 99, 683, 10.1111/1523-1747.ep12613748 Ribeiro, 1995, Hemostatic properties of the SV-40 transfected human microvascular endothelial cell line (HMEC-1). A representative in vitro model for microvascular endothelium, Thromb. Res., 79, 153, 10.1016/0049-3848(95)00101-V Ahmad, 1998, Role of activating protein-1 in the regulation of the vascular cell adhesion molecule-1 gene expression by tumor necrosis factor-alpha, J. Biol. Chem., 273, 4616, 10.1074/jbc.273.8.4616 Scholzen, 1999, Expression of functional melanocortin receptors and proopiomelanocortin peptides by human dermal microvascular endothelial cells, Ann. N.Y. Acad. Sci., 885, 239, 10.1111/j.1749-6632.1999.tb08681.x Zhong, 2002, HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells, Arterioscler. Thromb. Vasc. Biol., 22, 1560, 10.1161/01.ATV.0000034707.40046.02